
Guy Marius Sagna, a parliamentarian, has submitted a written question to the Senegalese government regarding the Institut Pasteur de Dakar's IPD position in the medical biology sector. Sagna raised concerns about alleged tax and customs exemptions benefiting IPD, which he believes could create unfair competition with private laboratories like Bio 24 and Solabsen. He questioned the ability to ensure equitable competition in public tenders if IPD can offer more competitive rates due to these advantages. Sagna also inquired about the evolution of IPD's mission, noting its historical focus on research, epidemiological surveillance, and vaccine production, and its current expansion into medical biology services for the general public. This diversification, he suggested, raises questions about the institution's original mandate and its potential impact on national private laboratories. Furthermore, the parliamentarian highlighted IPD's territorial expansion, including new facilities in Touba and other areas already served by similar structures, asking the government if these expansions comply with existing regulations or if they set a precedent that could weaken sector regulation.
Free daily or weekly digest of the most important stories from across 10 countries. No spam, unsubscribe any time.
This summary was AI-generated from a story originally published by SeneNews.